These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29667121)

  • 21. Single-molecule force spectroscopy reveals folding steps associated with hormone binding and activation of the glucocorticoid receptor.
    Suren T; Rutz D; Mößmer P; Merkel U; Buchner J; Rief M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11688-11693. PubMed ID: 30366952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
    Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
    J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unbinding pathways from the glucocorticoid receptor shed light on the reduced sensitivity of glucocorticoid ligands to a naturally occurring, clinically relevant mutant receptor.
    Capelli AM; Bruno A; Entrena Guadix A; Costantino G
    J Med Chem; 2013 Sep; 56(17):7003-14. PubMed ID: 23927519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor.
    Wan Y; Coxe KK; Thackray VG; Housley PR; Nordeen SK
    Mol Endocrinol; 2001 Jan; 15(1):17-31. PubMed ID: 11145736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
    Kroe RR; Baker MA; Brown MP; Farrow NA; Gautschi E; Hopkins JL; LaFrance RR; Kronkaitis A; Freeman D; Thomson D; Nabozny G; Grygon CA; Labadia ME
    Biophys Chem; 2007 Jul; 128(2-3):156-64. PubMed ID: 17466438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, purification, and characterization of multiple, multifunctional human glucocorticoid receptor proteins.
    Simmons CA; Bledsoe RK; Guex N; Pearce KH
    Protein Expr Purif; 2008 Nov; 62(1):29-35. PubMed ID: 18694832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering the structural basis for glucocorticoid resistance caused by missense mutations in the ligand binding domain of glucocorticoid receptor.
    Monteiro LLS; Franco OL; Alencar SA; Porto WF
    J Mol Graph Model; 2019 Nov; 92():216-226. PubMed ID: 31401440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric role of the amino-terminal A/B domain on corticosteroid transactivation of gar and human glucocorticoid receptors.
    Oka K; Hoang A; Okada D; Iguchi T; Baker ME; Katsu Y
    J Steroid Biochem Mol Biol; 2015 Nov; 154():112-9. PubMed ID: 26247481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational dynamics and molecular recognition: backbone dynamics of the estrogen receptor DNA-binding domain.
    Wikström A; Berglund H; Hambraeus C; van den Berg S; Härd T
    J Mol Biol; 1999 Jun; 289(4):963-79. PubMed ID: 10369775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor.
    Boruk M; Savory JG; Haché RJ
    Mol Endocrinol; 1998 Nov; 12(11):1749-63. PubMed ID: 9817600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations.
    Liu YL; Jang S; Wang SM; Chen CH; Li FY
    J Biomol Struct Dyn; 2016 Jun; 34(6):1214-31. PubMed ID: 26198481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing the stability and solubility of the glucocorticoid receptor ligand-binding domain by high-throughput library screening.
    Seitz T; Thoma R; Schoch GA; Stihle M; Benz J; D'Arcy B; Wiget A; Ruf A; Hennig M; Sterner R
    J Mol Biol; 2010 Nov; 403(4):562-77. PubMed ID: 20850457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homology modelling of the ligand-binding domain of glucocorticoid receptor: binding site interactions with cortisol and corticosterone.
    Dey R; Roychowdhury P; Mukherjee C
    Protein Eng; 2001 Aug; 14(8):565-71. PubMed ID: 11579225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase.
    Wang Z; Chen W; Kono E; Dang T; Garabedian MJ
    Mol Endocrinol; 2007 Mar; 21(3):625-34. PubMed ID: 17185395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first crystal structure of a DNA-free nuclear receptor DNA binding domain sheds light on DNA-driven allostery in the glucocorticoid receptor.
    Frank F; Okafor CD; Ortlund EA
    Sci Rep; 2018 Sep; 8(1):13497. PubMed ID: 30201977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.
    Vitellius G; Fagart J; Delemer B; Amazit L; Ramos N; Bouligand J; Le Billan F; Castinetti F; Guiochon-Mantel A; Trabado S; Lombès M
    Hum Mutat; 2016 Aug; 37(8):794-803. PubMed ID: 27120390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor alpha (hERalpha) LBD: quantitative structure-activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvement.
    Lewis DF; Ogg MS; Goldfarb PS; Gibson GG
    J Steroid Biochem Mol Biol; 2002 Oct; 82(2-3):195-9. PubMed ID: 12477485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function.
    Kino T; Liou SH; Charmandari E; Chrousos GP
    Mol Med; 2004; 10(7-12):80-8. PubMed ID: 16307173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.